Isabel Cuartas

Barcelona, CT 08035, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Development and Preclinical Evaluation of a Zirconium-89-Labeled Immunoconjugate for Positron Emission Tomography Imaging of Leukemia Inhibitory Factor in Glioblastoma.

Development and Preclinical Evaluation of a Zirconium-89-Labeled Immunoconjugate for Positron Emission Tomography Imaging of Leukemia Inhibitory Factor in Glioblastoma.

Journal: ACS pharmacology & translational science
Published: February 04, 2025

Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.

Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.

Journal: Nature
Published: July 03, 2024

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 01, 2024

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase.

Journal: Nature
Published: October 19, 2023

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma.

Journal: Molecular cancer therapeutics
Published: March 25, 2022

Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.

Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis.

Journal: Cancer research
Published: December 03, 2021

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.

Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program.

Journal: Acta neuropathologica
Published: May 20, 2019

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.

Journal: Nature communications
Published: March 28, 2019

Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining.

Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 30, 2018

p95HER2-T cell bispecific antibody for breast cancer treatment.

p95HER2-T cell bispecific antibody for breast cancer treatment.

Journal: Science translational medicine
Published: January 29, 2018

An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages.

An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 16, 2017

Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis.

Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis.

Journal: Nature communications
Published: February 18, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026